chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Just as the last of the Rotateq was being given, the patient suddenly arched his back, began choking and turned blue.  When he arrived at our clinic his O2 sats were 95 which is where they normally are, but after the vaccine it dropped to 93%.  When the doctor arrived in the room he was pale and dusky and looked postictal.  Due the this, and the fact that he was 26 weeker preemie, he was sent to the hospital via ambulance for further treatment.
I received the Moderna shot on Friday, 4/9/21.  On Saturday, I felt quite bad - lightheaded, and like I was getting sick (very slight sore throat).  On Sunday, I felt a lot better.  Today (Monday), I often feel light-headed/dizzy - especially when I sink my head low or move my head a lot.
None. Given Adacel Tdap instead of Boostrix. Medication error.
Live virus skin reaction 6" x 4.5" induration, hot, redness. Ice compresses, Tylenol and follow up if worsens. No fever.
Approximately 10 hours post vax, the pt developed neuropathy of his left leg with foot drop of the left side. Additional information is being requested. No further information is available.
Feeling flushed; Mild nausea; Unwell; This case was reported by a consumer via call center representative and described the occurrence of flushing in a 84-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2021, the patient received the 1st dose of Shingrix. In October 2021, less than 3 weeks after receiving Shingrix, the patient experienced flushing, nausea and unwell. The patient was treated with ambiguous medication nos (Cortisone (Nos)). On an unknown date, the outcome of the flushing, nausea and unwell were not recovered/not resolved.   It was unknown if the reporter considered the flushing, nausea and unwell to be related to Shingrix.   Additional details provided were as follows: The case was reported by patient himself. Age at vaccination was not reported. The patient stated that he and his wife both received their first dose of Shingrix 3 weeks ago. The patient stated that since receiving the vaccine he feels unwell, had periodic mild nausea and felt a little flushed (symptomatic).The patient  inquired if the side effects and their duration are common. Patient also inquired if he should get second dose. The patient stated his doctor prescribed Cortisone 20 mg once daily for 5 days for symptoms. No additional details provided by the patient. The reporter consented to follow-up. The case was linked with case US2021223578, reported by same reporter.
Within an hour of receiving vaccine, left eye became swollen and lids discolored. Feeling of increased intraocular pressure within the eye. Pain inside eyeball. Lids painful to touch. Clear/white ocular exudate extruded from eyeball. In middle of night, eye began "weeping". Seem to decrease pressure within the eyeball. Eye still swollen and discolored but not as painful 01/30/2021 0830.
2 hrs, onset fever lasting 9 days average temp 99.9 Headache, fatigue, 4/3-4/4 Brady cardia 60 bpm, 4/5 tachycardia 136bpm, increased arrhythmia activity 3/31 to present, leg pain 4/9 to present, nerve pain, swollen lymph nodes, increased headaches 3/31-4/14, blurred vision, intense fatigue w/extreme exhaustion after moderate activity like walking around grocery store
tested positive after 5 days of receiving their 1st dose of the vaccine last 07MAR2021; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported a male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Not reported and expiration date not reported) via an unspecified route of administration on 07Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that on 12Mar2021, tested positive after 5 days of receiving their first dose of the vaccine last 07Mar2021 (covid-19). The patient underwent lab tests which included, sars-cov-2 test: positive on 12Mar2021 after 5 days of receiving their 1st dose of the vaccine, unknown date in Mar2021 sars-cov-2 test: negative, they got their monoclonal infusion 3 days after they tested positive. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021353595 same product, AE/ different patient.
Dystonic storm that lasted 45 minutes; Pain radiating from feet up; Pain radiating from feet up; This is a spontaneous report received a contactable consumer, the patient. A 24-year-old adult female received the second dose of BNT162b2 (solution for injection; Lot ER8733 expiry information not provided) via unspecified route in the right arm on 05Apr2021 at 10:45 (at 24-years-old) for COVID-19 immunisation. Relevant medical history included CTNNB1, Klippel Feil syndrome, dystonia, spastic tetraplegia, and pulmonary stenosis. The patient denied any known allergies. Concomitant medications included baclofen, carbidopa/ levodopa (SINEMET), omeprazole, diazepam (VALIUM), and nortriptyline. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (Lot EN6203) in the right arm on 13Mar2021 at 10:45 (at 24-years-old). It was reported unknown if the patient was diagnosed with COVID-19 prior to the vaccine. The patient denied receiving any other vaccine within four weeks of this vaccine. The patient reported that on 06Apr2021 at 17:30 he experienced a dystonic storm lasting forty-five minutes and pain radiating from his feet. It was unknown if treatment was received for the events. The patient has not been tested for COVID-19 since the vaccine. The outcome of the events dystonic storm lasting forty-five minutes and pain radiating from his feet was recovered with sequelae (described as lasting effects) on an unspecified date in Apr2021.
While administering the vaccine, most of the vaccine liquid came out near the top which I believe happened from the syringe not being screwed on all the way.  A new dose was administered in the other arm.
neck hurting; body hurting; vomiting; fever; sick; This is a spontaneous report from a contactable nurse. This nurse reported for a male patient (reporter's grandson) that.  A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 25Aug2021 13:00 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 for COVID-19 immunization. The patient experienced neck hurting, body hurting, vomiting, fever, sick on an unspecified date. It was reported that Caller is calling on behalf of her grandson who received the second dose of the Pfizer Covid-19 vaccine 25Aug2021 1 PM (time zone not provided) and now he is having complaints of his neck hurting, body hurting, vomiting, and fever per Reugulatory Authority. Caller declined to provide a safety report, zip code, and age of grandson. Caller is asking if she should have her grandson go to a hospital. Call was disconnected before warm transfer could occur. Callback at 2:10 PM EST 26Aug2021. Confirmed above information and inquiry with Caller. Caller also stated that her grandson is "super sick" and in "super pain". The events were assessed as Non serious by reporter. The outcome of events was unknown.  The lot number for [BNT162B2], was not provided and will be requested during follow up
Information has been received from a pharmacist concerning a 11 year old female who was vaccinated  with two doses of GARDASIL.  There was no concomitant medication.  Subsequently, "one day after the second dose", the patient experienced severe leg pain and hurt to walk.  It was reported that the patient recovered, but no time to recovery reported.  This is one of several reports from the same source.  Additional information has been requested.
Fever increased to 101, Diarrhea, vomiting, since immunization 8/11/05.
Patient developed a fever of 104 within 2 hours of receiving the vaccine. He did this in 2010 as well after receiving the vaccination.
fever; golf ball size swelling on her arm; arm was in pain; Headache; This case was reported by a pharmacist via patient support programs and described the occurrence of fever in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 21st November 2019, the patient received the 2nd dose of Shingrix 1 ml. On an unknown date, less than a month after receiving Shingrix, the patient experienced fever, swelling arm, pain in arm and headache. On an unknown date, the outcome of the fever, swelling arm, pain in arm and headache were recovered/resolved.   It was unknown if the reporter considered the fever, swelling arm, pain in arm and headache to be related to Shingrix.  Additional details were provided as follows: The patient had a fever for two days after the second shot,a golf ball size swelling on her arm that lasted for five days, arm was in pain for ten days and also a headache for as long as the fever lasted. The follow up consent was granted.
Patient came back at around 5:15pm and told pharmacist about numbing/tingling feeling on cheeks.  He didn't experience any other symptoms.  He has never experienced any sensation like this before.
Patient noticed later in the day after receiving the vaccine feeling dizzy, nauseous, and overall not well. Their arm was sore and swollen. The following day the swelling was evident and the discomfort was in the neck and arm. The swelling traveled to the elbow area. The patient was advised to contact their provider about the adverse reaction and to take Benadryl and ice the area to subside the reaction. The patient stated Benadryl also made her nauseous. The patient waited a few days and the reaction, soreness, and ill feelings subsided some. There was still some swelling. The patient finally contacted the doctor by day 7.
Pneumonia due to infectious organism. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Swelling at site of injection, spreading down the arm with associated T 103. Started about 5-6 hours post injection.
immunocompromised; Shingles; vaccination failure; This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 26th February 2018, the patient received the 1st dose of Shingrix. On 17th May 2018, the patient received the 2nd dose of Shingrix. On 9th July 2019, 1 year and 133 days after receiving Shingrix and 1 year and 53 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced immunocompromised (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure, immunocompromised and shingles were unknown.   It was unknown if the reporter considered the vaccination failure, immunocompromised and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The register pharmacist (RPH) reported that patient received the Shingrix series dose 1 and dose 2. The patient was immuncompromised and had Shingles 10 days ago. The reporter asked that what was the safety on receiving an additional series. The reporter was consented to follow up.
local erythema/edema 8x10cm mid lateral thigh, firm onset 28hr p/vax;
This case was reported by a vaccine distributor and described the occurrence of welt form on the injection site in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline) for Prophylaxis. On an unspecified date the subject received unspecified dose of Flulaval (unknown). At an unspecified time after vaccination with Flulaval, the subject developed a welt at the injection site. The welt was about two inches across, and looked very similar to a bug bite. At the time of reporting the outcome of the event was unspecified.
Patient spiked fevers, with the highest one marked at 107. Red, sore arm. Achy, weak. Symptoms lasted >7 days. Went to hospital. Had bloodwork and cultures done to rule out other illnesses. Wanted to put patient in an ice bath because of his high fever. Could not determine if this was due to vaccinations or not.
Initial and follow up information has been received from a physician concerning a 12 month old male patient with no history of allergies, a trait of Mediterranean anemia, a platelet count of 481,000 on 4/30/99 and a platelet count of 517,000 on 6/8/99. ON 7/7/99 the patient was vaccinated with a first dose of MMR (lot # 630625/0353J). The physician reported that 3 weeks posts vaccination the child developed idiopathic thrombocytopenic purpura. On 7/28/99 the patient presented to the office with red dots on his neck and face. A CBC was done and laboratory evaluation revealed a white blood cell count of 9.1, hemoglobin of 11.1, hematocrit of 34 and a platelet count of 5,000. The patient was sent to a hematologist. The physician reported that he did not think that the child was hospitalized, but was treated with gamma globulins. On 8/6/99 laboratory evaluation revealed that the child's platelet count was back to normal at 508,000 and on 8/19/99 the platelet count was normal at 228,000. The patient fully recovered. He received his second dose of MMR and it was reported on 11/6/03 that he has not had any problems. Upon internal review, idiopathic thrombocytopenic purpura was determined to be an other important medical event (OMIC). No further information is available.
No adverse event; doses administered after excursion; Prior to knowing that the vaccines underwent a temperature excursion in the freezer, patient received doses of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Prior to knowing that the vaccines underwent a temperature excursion in the freezer, patient received doses of the vaccine) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Prior to knowing that the vaccines underwent a temperature excursion in the freezer, patient received doses of the vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Prior to knowing that the vaccines underwent a temperature excursion in the freezer, patient received doses of the vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Prior to knowing that the vaccines underwent a temperature excursion in the freezer, patient received doses of the vaccine).    Concomitant medications details were not reported by the reporter.  Reportedly, Pharmacist called to discuss a temperature excursion that occurred several days ago in the freezer. the excursion was found out in an audit and all the vaccines were viable.  Treatment details were not reported by the reporter.
RINGING IN EARS; This spontaneous report received from a consumer concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch numbers were not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced ringing in ears. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of ringing in ears was not reported. This report was non-serious.
feet are swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. Other Case identifier(s): US-PFIZER INC-2021606922 (Pfizer).   A 79 year-old male patient received bnt162b2 (BNT162B2), administration date 07May2021 (Batch/Lot number: unknown) at the age of 79 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset May2021, outcome "unknown", described as "feet are swollen". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Reporter of adverse event: Patient: Summary of adverse event: went to emergency room due to side effects of coronavirus booster vaccine. had difficulty walking and was released to a long term care facility for 3 weeks; date of occurrence 01/2022. no further information was provided; MD aware and drug therapy continues unchanged
In the middle of the night, Wednesday morning, my eyelids were swollen.  Left eyelid more than right eyelid.  Then waking up at 11:30am Wednesday, the swelling was still there, right eyelid more than left eyelid.  I took a tablet of Cetrizin antihistamine at around 12:30pm.  Around 4pm, the swelling was still there, now left eyelid more than right eyelid.  I took Benedryl at around 11pm, but upon awakening in the morning (Thursday), the swelling is still present, still left eyelid more than right eyelid.  No pain, but there is tenderness of the left eyelid.    I had mild fever, chills, muscle pain, fatigue, headache in the middle of the night after receiving the second dose of the vaccine on Tuesday.  This has subsided.  Mild headache still remains.
very low grade fever; it was 99.5 degrees Fahrenheit; getting a GI cold; Arm pain; General fatigue; This is a spontaneous report from a contactable nurse, reporting for herself. A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1685), via an unspecified route of administration at the left arm on 17Dec2020 at single dose for COVID-19 vaccination. Vaccination was done in a hospital. Medical history included celiac disease from 2011 and ongoing (very well controlled, she eats gluten-free. This is an autoimmune disease, but she is not immunocompromised like they ask with the Pfizer COVID-19 Vaccine. She is typically very healthy) and irritable bowel syndrome from an unknown date and unknown if ongoing. There were no concomitant medications. It was reported that following the first dose, she just experienced arm pain and general fatigue, just the basics. Arm pain and general fatigue with first dose she described as she did not really have a negative effect from; just the basics what everyone was saying. She did not feel anything when the first dose was injected; she did not have any issues until about 3 hours later that day on 17Dec2020 when she had onset of arm pain and general fatigue where she just felt tired for a few days; nothing big; she was able to work after the first dose; she just took ibuprofen for the first 2 days and the arm pain went away. She also mentioned that before getting the second dose of the vaccine she had a very low grade fever; it was 99.5 degrees Fahrenheit but she felt fine. Her stomach she was kind of having a little issue with loose stools for a few days before the second dose of the vaccine. She had celiac disease and a history of irritable bowel syndrome; and her uncle died on 02Jan2021 so she blamed the symptoms going on stress due to that. She does not know if maybe she was getting a GI cold at that time, the symptoms were a little mild before getting the second dose of the vaccine, she never felt sick or anything like that. She told the doctor about these symptoms during her appointment on 06Jan2021. Seriousness criteria of very low grade fever and a little issue with loose stools unknown. The patient underwent lab tests and procedures which included body temperature: 99.5 degrees fahrenheit on an unspecified date and COVID-19 test: negative on 06Jan2021. The outcome of the events was unknown. The reporter assessed the events arm pain and general fatigue as related to BNT162B2.
"normal" reaction including site pain, redness, swelling, fever, chills, extreme fatigue, headache.  also developed less common rashes all over body, as I did with the first shot.  this time, the fatigue and headaches were severe and all over muscle pain is severe.  I missed the entire following week of work and am still experiencing severe body pain, fatigue and migraines.  doctors do nothing, just say I'm a long hauler (had moderate-severe covid 19 in October, 2020) and there's nothing they can do.  I have experienced long covid symptoms since I had covid, but my health has deteriorated severely since having these 2 vaccines.
Left arm is swollen, hot and red on the underneath side from elbow to axilla. Also painful.